Mechanistically, EM900 was found to significantly decrease the expression of asthma-associated inflammatory mediators such as IL-5, IL-13, CCL5 and CXCL2 by lung interstitial macrophages, via the suppression of NF-κB and p38 signaling (181). The gene discussed is IL13; the disease is asthma.